You have 9 free searches left this month | for more free features.

DMPA injection

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Vaccine Reaction Trial in Bandung (Gardasil, PharmaJet Stratis® Needle-Free Injection System, PharmaJet Tropis® Needle-Free

Not yet recruiting
  • Vaccine Reaction
  • Bandung, Indonesia
    Universitas Padjadjaran
Nov 16, 2023

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Advanced Squamous Non-Small Cell Lung Carcinoma Trial in Beijing, Tianjin, Kunming (TQB2450, Anlotinib HCl capsule, Tislelizumab

Not yet recruiting
  • Advanced Squamous Non-Small Cell Lung Carcinoma
  • Beijing, Beijing, China
  • +3 more
Feb 12, 2023

HIV-1 Infection, Tuberculosis Trial in Worldwide (Depot medroxyprogesterone acetate)

Completed
  • HIV-1 Infection
  • Tuberculosis
  • Depot medroxyprogesterone acetate
  • Gaborone, Botswana
  • +4 more
Jun 13, 2019

Excessive Gingival Display Trial (procedure, device, drug)

Not yet recruiting
  • Excessive Gingival Display
  • Botox injection
  • +2 more
  • (no location specified)
Oct 3, 2023

Knee Osteoarthritis, Osteo Arthritis Knee Trial (Microfragmented Adipose Tissue derived using the Lipogems® System, Saline

Not yet recruiting
  • Knee Osteoarthritis
  • Osteo Arthritis Knee
  • Microfragmented Adipose Tissue derived using the Lipogems® System
  • Saline Injection
  • (no location specified)
Nov 2, 2023

Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

Recruiting
  • Adenocarcinoma of Stomach
  • Gentuximab Injection
  • Gentuximab Injection Placebo
  • Shanghai, Shanghai, China
    Shanghai Dongfang Hospital
Jun 16, 2023

Acute Myeloid Leukemia, MDS Trial in China (TQB2928 Injection + Azacitidine for injection)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • TQB2928 Injection + Azacitidine for injection
  • Beijing, Beijing, China
  • +8 more
Aug 22, 2023

Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

Not yet recruiting
  • Cutaneous Warts
  • Hepatitis B Virus Vaccine(HBV)
  • (no location specified)
Jun 13, 2023

Acute Gout Trial in Shanghai (genakumab, for Diprospan, for genakumab)

Recruiting
  • Acute Gout
  • Shanghai, Shanghai, China
    Fudan University Affiliated Huashan Hospital
Aug 6, 2023

Nail Psoriasis Trial in Assiut (Excimer laser, Methotrexate Injection)

Not yet recruiting
  • Nail Psoriasis
  • Excimer laser
  • Methotrexate Injection
  • Assiut, Egypt
    Faculty of Medicine
Nov 28, 2023

Stroke Trial in Kastamonu (The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection

Completed
  • Stroke
  • The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection Applied to the Upper Arm Region
  • Kastamonu, Turkey
    Kastamonu University
Oct 6, 2023

Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal

Recruiting
  • Pain
  • +2 more
  • Use of bromfenac 0.09% to reduce intravitreal injection pain
  • Use of artificial tears to reduce intravitreal injection pain
  • Boston, Massachusetts
  • +4 more
Nov 8, 2023

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain Trial in Houston (PNS therapy, Triamcinolone, Bupivacaine)

Recruiting
  • Peripheral Nerve Stimulation
  • +2 more
  • PNS therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 15, 2023

Hysterotomy; Affecting Fetus Trial (Naropeine, questionnaires, Placebo)

Not yet recruiting
  • Hysterotomy; Affecting Fetus
  • (no location specified)
Jul 27, 2023

Advanced Solid Tumor Trial in Zhengzhou, Linyi (BAT4706 Injection, BAT1308 Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • BAT4706 Injection
  • BAT1308 Injection
  • Zhengzhou, Henan, China
  • +2 more
Nov 14, 2023

Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

Completed
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Relapsed or Refractory Multiple Myeloma
  • BEBT-908 for injection
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 9, 2023

Spinal Anesthesia, Hyperbaric Bupivacaine, Isobaric Bupivacaine Trial in Helwan (Group A (hyperbaric bupivacaine), Group B

Completed
  • Spinal Anesthesia
  • +3 more
  • Group A (hyperbaric bupivacaine)
  • Group B (Mixture of Hyperbaric and Isobaric Bupivacaine)
  • Helwan, Cairo, Egypt
    Helwan University
Sep 17, 2023

Gastric Varices Bleeding, Liver Decompensation Trial in Kaohsiung (Sodium tetradecyl sulfate, Cyanoacrylate)

Recruiting
  • Gastric Varices Bleeding
  • Liver Decompensation
  • Kaohsiung, Taiwan
    Kaohsiung Veterans General Hospital
Oct 24, 2023

Safety and Performance of the SYNOVIUM HCS Device

Recruiting
  • Gonarthrosis
  • Intra-articular injection of hyaluronic acid
  • Saint-Brieuc, France
    CRRF en Milieu Marin de Trestel
Oct 13, 2023

Patient Awareness About Possibility Of Occurrence Of Pain During

Not yet recruiting
  • Effect of Patient Awareness on Incidence and Severity of Propofol Injection Induced Pain
  • Awareness about propofol injection induced pain
  • (no location specified)
Jun 1, 2023

Type 2 Diabetes Trial in Shanghai (THDB0206 Injection, Insulin Lispro Injection)

Recruiting
  • Type 2 Diabetes
  • THDB0206 Injection
  • Insulin Lispro Injection
  • Shanghai, China
    Zhongshan Hospital
Apr 17, 2023

Bioequivalence, Therapeutic Equivalency Trial in Moscow (Humulin® Regular, Rinsulin® R)

Completed
  • Bioequivalence
  • Therapeutic Equivalency
  • Humulin® Regular
  • Rinsulin® R
  • Moscow, Russian Federation
    "National Medical Research Center of Endocrinology" of the Minis
Sep 15, 2023

Dermal Filler Trial (Formaderm Dermal Filler Injection, "Q-MED" RESTYLANE)

Completed
  • Dermal Filler
  • Formaderm Dermal Filler Injection
  • "Q-MED" RESTYLANE
  • (no location specified)
Apr 20, 2023